Lasolle, H., Hadoux, J., Hescot, S., Jannin, A., Godbert, Y., Sarradin, V., Lugat, A., Niccoli, P., Garcia, M., Vinches, M., Burgy, M., Vicier, C., Tomasini, P., Tosi, D., Calattini, S., Bin, S., Subtil, F., You, B., Béguinot, M. (2025). IMMUNORARE
            <sup>5</sup>
            : A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The Anaplastic Thyroid Carcinomas Cohort.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps2693